Navigation Links
MediciGlobal Achieves Record Number of Awards
Date:7/16/2009

PHILADELPHIA and LONDON, July 16 /PRNewswire/ -- Since January 2009, MediciGlobal has received a record number of national and international awards for its work in patient education and design. In June, 2009 MediciGlobal announced that it was the recipient of four 2009 Communicator Awards from the International Academy of the Visual Arts for various programmes. On July 9th, the company was further notified of six more awards (two silver, and two bronze) from the 16th Annual National Health Information Awards and two bronze awards from The 26th Annual Healthcare Advertising Awards. These awards all honour the best examples of creative healthcare information, programmes and materials for consumers.

MediciGlobal, a leading company in the development of patient recruitment, retention and education programmes for clinical trials, won its awards on behalf of five global pharmaceutical clients. The programmes covered a range of medical conditions including: depression, preterm pregnancy, restless leg syndrome, menopause, clinically isolated syndrome (CIS); pre-diagnosed Multiple Sclerosis, and teen migraine.

From 2007, MediciGlobal has received a total of 16 national and international awards for its patient recruitment and retention programmes. "This broad recognition demonstrates the quality and importance of our work. Our team develops patient-focused programmes that are innovative, adhere to health literacy guidelines and deliver results," said Liz Moench, MediciGlobal's President and CEO.

"Beyond these awards however, the best mark of success and recognition comes with their use." Moench adds. "Our programmes are successful when they help patients with their decision-making, such as joining a clinical trial, and when research staff finds them supportive in explaining study details to patients and families."

About MediciGlobal

MediciGlobal based in the U.S. and U.K., is a specialty patient recruitment - retention company, developing patient-centric programmes for clinical trials of all sizes, and in countries around the globe. MediciGlobal's patient recruitment and retention programmes ensure that biopharmaceutical and life sciences companies accelerate the enrolment process for clinical trials. MediciGlobal is one of few companies focused solely on patient recruitment and retention for almost two decades. www.mediciglobal.com


'/>"/>
SOURCE MediciGlobal
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MediciGlobal Wins Four International 2009 Communications Awards for Patient Recruitment and Retention
2. OH2 Medical Spa Achieves the First U.S. LEED(R) Certification for a Medical Commercial Interior
3. Journal of Alzheimers Disease once again achieves significant impact factor increase
4. Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman
5. OpusClinicalSuite(R) Achieves 08 CCHIT Certification as Inpatient EHR
6. IncentOne Achieves 2 Millionth Health Milestone
7. Misonix Subsidiary, Sonora Medical Systems, Achieves ISO 17025 Accreditation
8. InstaMed Achieves CAQH CORE Rules Certification, Streamlines Provider Access to Consistent Electronic Eligibility, Benefits and Patient Financial Liability Data
9. Pamela Lyon, M.D. Achieves Board Certification in Bariatric, Weight Loss Medicine
10. InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early
11. The Larry King Cardiac Foundation Achieves Record Life-Saving Pace With Help From New Friends and Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: